ACR# responses

Related by string. ACR# response * ACR# [002] . ACR# [001] : ACR# ACR# . achieved ACR# / re sponse . Responses . RESPONSE . RESPONSES . Response : Computer Emergency Response . Emergency Response Team . Community Emergency Response . Complete Response Letter . Complete Response letter . Rapid Response Team . Crisis Response . response . Oil Spill Response . Rapid Response . sustained virologic response * *

Related by context. Frequent words. (Click for all words.) 68 plus methotrexate 67 virologic response 66 sustained virologic response 66 ACR# [002] 65 adalimumab 64 cytogenetic response 64 plus dexamethasone 64 annualized relapse 63 mg BID 63 mg kg dose 63 neoadjuvant therapy 62 tocilizumab 62 IPSS 62 degarelix 62 undetectable viral load 62 achieved statistical significance 61 COPAXONE R 61 DAS# [002] 61 mg QD 61 mycophenolate mofetil 61 inflammatory lesions 61 certolizumab pegol 61 laboratory abnormalities 61 plus prednisone 60 virologic failure 60 RECIST criteria 60 antibody titers 60 complete remissions 60 mcg dose 60 decitabine 60 chemoradiotherapy 60 neoadjuvant chemotherapy 60 STELARA 60 febuxostat 60 Amrubicin 60 serum concentrations 60 placebo p = 60 peginterferon alfa 2a 60 serum uric acid 60 unresectable 59 placebo p 59 PROMACTA 59 evaluable patients 59 serum phosphorus 59 evaluable 59 FOLFIRI 59 adefovir 59 limiting toxicity 59 mcg kg 59 T2DM 59 tipranavir 58 nonresponders 58 relapsed refractory multiple myeloma 58 hemoglobin concentration 58 Gemcitabine 58 azacitidine 58 seroconversion 58 XELOX 58 & s2 = 58 etanercept 58 metastatic renal cell carcinoma 58 Solid Tumors 58 distant metastases 58 refractory multiple myeloma 58 active comparator 58 Cmax 58 ADAS cog 58 Arch Intern Med 58 administered subcutaneously 58 thromboembolic events 58 belimumab 58 HBV DNA 58 neoadjuvant 58 median PFS 58 tolvaptan 58 #mg dose [003] 58 darbepoetin alfa 58 creatinine clearance 58 androgen independent 58 lymphopenia 57 tumor shrinkage 57 TNF antagonists 57 HER2 positive metastatic breast 57 glycated hemoglobin 57 LymphoStat B 57 LVEF 57 severe renal impairment 57 tamsulosin 57 Arch Neurol 57 androgen deprivation 57 secondary efficacy endpoints 57 LIALDA 57 breast carcinoma 57 cabazitaxel 57 histologically 57 J Natl Cancer Inst 57 noninferiority 57 HER2 negative 57 TORISEL 57 HbA1c levels 57 hypercalcemia

Back to home page